Raltegravir
| CAS No. | 518048-05-0 | Cat. No. | BCP01394 |
| Name | Raltegravir | ||
| Synonyms | MK-0518; MK 0518; MK0518; | ||
| Formula | C20H21FN6O5 | M. Wt | 444.15 |
| Description | Raltegravir is an integrase inhibitor, the first of the class of antiviral agents active against the human immunodeficiency virus (HIV) that targets the viral integrase. Raltegravir is used in combination with other antiretroviral agents in the treatment of HIV infection. Raltegravir has not been linked convincingly to serum aminotransferase elevations during therapy or to episodes of acute, clinically apparent liver injury. | ||
| Related Products | 871038-72-1（Raltegravir potassium） | ||
| Pathways | Protease/Metabolic Enzyme Microbiology/Virology | ||
| Targets | Integrase HIV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.